We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




AI Tool Predicts Cancer Survival and Biological Age from Single Facial Photo

By HospiMedica International staff writers
Posted on 21 Oct 2026

Assessing frailty and physiologic reserve remains challenging when clinicians consider intensive cancer treatment. More...

Chronological age alone may not reflect how well a patient can tolerate radiation, surgery, or systemic therapy, complicating personalized treatment decisions for older adults. To provide a more individualized assessment, researchers have developed AI facial health recognition tools that estimate biological age and predict survival risk from a single facial photograph.

Mass General Brigham (Boston, MA, USA) developed Foundation Artificial Intelligence for Health Recognition, or FAHR-Face, as a large AI foundation model for facial health analysis. Trained on more than 40 million face images, the model was then used to create two complementary tools for assessing health in cancer care and aging research.

FAHR-FaceAge estimates biological age from a facial photograph and outperformed previous age-estimation algorithms, while FAHR-FaceSurvival predicts survival outcomes in patients with cancer. Although both tools were derived from the same foundation model, they captured different aspects of patient health.

In the development and validation study, the difference between a patient’s FAHR-FaceAge and chronological age was independently associated with survival. FAHR-FaceAge and FAHR-FaceSurvival were only weakly correlated, and both remained independently associated with survival when analyzed together. Combining the two measures also improved survival-model fit in an external validation cohort of patients with cancer.

The tools also relied on different facial regions for their predictions. FAHR-FaceAge focused on the nasolabial folds, the forehead area above the orbits, and the temples. FAHR-FaceSurvival evaluated the region below the eyes and around the nasal bridge. The findings were published in The Lancet Digital Health on October 19, 2026.

The study also linked lifestyle factors with facial aging. Heavy alcohol use, drug use, and smoking were associated with looking biologically older. Smoking showed the strongest pattern, with current smokers appearing older than former smokers, and former smokers appearing older than people who had never smoked. FAHR-FaceAge remained consistent across common photo variations, including pose, lighting, facial expression, and makeup, and was stable across most tested plastic surgery procedures, with only a small shift after rhinoplasty.

Related Links
Mass General Brigham


Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Medical Adhesive
MED 5570U
Surgical Dressing
ALLEVYN Ag+ SURGICAL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: Masimo smartSET pulse oximetry with PPG AFib and OIRD Detection (Photo courtesy of Masimo)

Smart Pulse Oximetry Supports Earlier Recognition of Arrhythmias and Respiratory Risk

On general care floors, respiratory compromise and arrhythmias can develop between routine checks. Atrial fibrillation often goes undiagnosed in older adults, while opioid-induced respiratory depression... Read more

Patient Care

view channel
Image: Researchers evaluated the Omni 128 cm long-axial field-of-view PET/CT system, which captures more of the body and radiotracer signal at once, potentially enabling shorter scans. (Photo courtesy of GE HealthCare)

Total-Body PET/CT Scanner Enables One-Minute Diagnostic-Quality Cancer Imaging

Positron emission tomography/computed tomography (PET/CT) combines radiotracer-based functional imaging with anatomical detail to diagnose, stage, and monitor cancer. Conventional scanners image the body... Read more

Medical Imaging

view channel
Image: Visual Abstract (Sinuo Gao, Zhaoqi Zhang, Chao Shi, Cheng Cheng, Xindi Ma, Xinming Zhao, Yunjiang Liu Journal of Nuclear Medicine Oct 2026, 67 (10) 1552-1559; DOI: 10.2967/jnumed.125.271529)

Targeted PET/CT Predicts Early Treatment Response in HER2-Positive Breast Cancer

HER2-positive breast cancer is an aggressive subtype that accounts for a substantial proportion of breast cancer cases. Patients often receive neoadjuvant therapy before surgery to shrink tumors, but assessing... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.